Eli Lilly and Company
NYSE:LLY
$ 363.95
$-1.82 (-0.50%)
$ 363.95
$-1.82 (-0.50%)
End-of-day quote: 11/29/2022

LLY - Eli Lilly and Stock Prediction 2025 - 2030

Reliable Eli Lilly and stock prediction from 12 Wall Street analysts. See at a glance if NYSE:LLY is undervalued and recommended to buy.

$184.67
Forecast 2022
$302.89
Forecast 2025
$431.11
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2022
$184.67
Forecast 2025
$302.89
Forecast 2030
$431.11
TopGraphs Quality Ranking
Neutral

Eli Lilly and Stock Forecast 2022

$392.00

In the last five quarters, Eli Lilly and’s Price Target has risen from $194.18 to $333.19 - a 71.59% increase. Twelve analysts predict that Eli Lilly and’s share price will increase in the coming year, reaching $392.00. This would represent an increase of 17.65%.

7.71%
7.71

Highest Price Target $436.00

Average Price Target $392.00

Lowest Price Target $202.00

Eli Lilly and Stock Prediction 2025

Eli Lilly and Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $254.46. An increase of 30.08% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $258.87. An increase of 28.87% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $263.27. An increase of 27.66% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $267.67. An increase of 26.45% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $272.07. An increase of 25.24% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $276.47. An increase of 24.04% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $280.88. An increase of 22.83% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $285.28. An increase of 21.62% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $289.68. An increase of 20.41% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $294.08. An increase of 19.2% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $298.48. An increase of 17.99% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $302.89. An increase of 16.78% compared to the previous month's estimate.

Eli Lilly and Stock Forecast 2030

Stock Forecast for the Price of an Eli Lilly and Share in Jan 2030.

In January 2030, analysts believe the stock price will be $414.52. An increase of 13.89% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Feb 2030.

In February 2030, analysts believe the stock price will be $416.02. An increase of 14.31% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Mar 2030.

In March 2030, analysts believe the stock price will be $417.53. An increase of 14.72% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Apr 2030.

In April 2030, analysts believe the stock price will be $419.04. An increase of 15.14% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in May 2030.

In May 2030, analysts believe the stock price will be $420.55. An increase of 15.55% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Jun 2030.

In June 2030, analysts believe the stock price will be $422.06. An increase of 15.97% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Jul 2030.

In July 2030, analysts believe the stock price will be $423.57. An increase of 16.38% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Aug 2030.

In August 2030, analysts believe the stock price will be $425.08. An increase of 16.8% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Sep 2030.

In September 2030, analysts believe the stock price will be $426.59. An increase of 17.21% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Oct 2030.

In October 2030, analysts believe the stock price will be $428.09. An increase of 17.62% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Nov 2030.

In November 2030, analysts believe the stock price will be $429.60. An increase of 18.04% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Dec 2030.

In December 2030, analysts believe the stock price will be $431.11. An increase of 18.45% compared to the previous month's estimate.

Company Info

P/E Ratio
21.3
Beta
0.36
Price-to-book Ratio
32.52
Market Cap
345.82B
TEV
288.563 B
LT Debt/Cap
0.06%
Dividend
$3.89
Div Yld
1.07%
Forecast 1Y
-48.37%
Forecast 2Y
-41.04%
Analyst Price Target
$333.19

About Eli Lilly and

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.

Eli Lilly and Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
21.3
Beta
0.36
Price-to-book Ratio
32.52
Market Cap
345.82B
TEV
288.563 B
LT Debt/Cap
0.06%
Dividend
$3.89
Div Yld
1.07%
Forecast 1Y
-48.37%
Forecast 2Y
-41.04%
Analyst Price Target
$333.19

Financials

Year Year 2020 2021
Rev. Revenue
24539.80 28318.40
GM % Gross Margin %
77.7 75.4
OI Operating Income
7101.40 8177.50
OM Operating Margin
28.94 28.88
NI Net Income
6193.70 5581.70
EPS % Earnings Per Share %
7.93 8.16
Div. Dividends
2.96 3.40
PR % Payout Ratio %
37.33 41.67
Sha. Shares
907 904
OCF Operating Cash Flow
6500 7261
CS Cap Spending
-1388 -1310
FCF Free Cash Flow
5112 5951
FCFS Free Cash Flow Per Share
4.93 5.94

Eli Lilly and Analyst Ratings Frequently Asked Questions

Who are the analysts watching Eli Lilly and Company?

The following analysts have recently covered Eli Lilly and:

Argus Research Company
Atlantic Equities LLP
Baptista Research
Barclays
Berenberg
BMO Capital Markets Equity Research
BofA Global Research
Cantor Fitzgerald & Co.
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Cowen and Company
Daiwa Securities Co. Ltd.
Day By Day
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Marktfeld
Mirae Asset Securities Co., Ltd.
Morgan Stanley
Morningstar Inc.
Societe Generale Cross Asset Research
Truist Securities
Wells Fargo Securities, LLC
Wolfe Research, LLC.
Moody’s
UBS Investment Bank
SVB Securities LLC
CLSA
Millennium BCP
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Eli Lilly and Company?

The following sell-side analysts have recently covered Eli Lilly and:

Chesney, Steven Kent
Majumdar, Ishan
Gould, Carter Lewis
Holford, Kerry Ann
Seigerman, Evan David
Meacham, Geoffrey Christopher
Chen, Louise Alesandra
Glickman, Stewart
Baum, Andrew Simon
Scala, Stephen Michael
Nakagiri, Narumi
Shibutani, Chris
Fernandez, Seamus Christopher
Schott, Christopher Thomas
Paraskevopoulos, Michail
Kim, Seung-min
Conover, Damien
Cespedes, Florent
Karnauskas, Robyn Kay Shelton
Bansal, Mohit
Anderson, Timothy Minton
Flynn, Terence C.
Hellweg, Jasper
Bristow, Colin Nigel
Risinger, David Reed
Raffat, Umer
Gastaldy, Valérie
Fan, Hans Haishuo
Kumaar, Mohit
Loureiro, Ramiro
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy